NEW YORK (GenomeWeb News) – Olink Bioscience has signed up AH Diagnostics to distribute its proteomics research technology in Denmark and Norway.
Under the agreement, AH Diagnostics will distribute the Duolink proximity ligation assay technology in the two Nordic nations.
The in situ Duolink technology is used to extend the capabilities of traditional immunoflourescence and immunohistochemsitry and to include direct detection of proteins, protein interactions, and modifications.
AH diagnostics is a supplier for academic institutions, hospitals, and the pharmaceutical industry.
Last week, Olink announced a similar distribution agreement with Finnish firm Immuno Diagnostic to market its Duolink systems in Finland.